Infliximab induced liver injury in Crohn's disease: A challenging diagnosis

Journal of Crohn's and Colitis

Volumn 8, Issue 5, 2014, Pages 436-437

  Carvalheiro, Joana ^a   Mendes, Sofia ^a   Sofia, Carlos ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; BUDESONIDE; GAMMA GLUTAMYLTRANSFERASE; INFLIXIMAB; MESALAZINE; GASTROINTESTINAL AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; CASE REPORT; CHOLESTASIS; CHRONIC HEPATITIS; CROHN DISEASE; ECHOGRAPHY; HUMAN; HUMAN TISSUE; ILEITIS; LETTER; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER INJURY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SEROLOGY; YOUNG ADULT; DIFFERENTIAL DIAGNOSIS; DRUG-INDUCED LIVER INJURY, CHRONIC; HEPATITIS, CHRONIC;

ADULT; ANTIBODIES, MONOCLONAL; CHOLESTASIS; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; DRUG-INDUCED LIVER INJURY, CHRONIC; GASTROINTESTINAL AGENTS; HEPATITIS, CHRONIC; HUMANS; LIVER FUNCTION TESTS; MALE;

EID: 84897414570     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.11.013     Document Type: Letter

References (5)

1. Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut Jun 2006, 55(6):749-753.
2. Tajiri K., Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol Nov 28 2008, 14(44):6774-6785.
3. Khokhar O.S., Lewis J.H. Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis 2010, 28(3):508-518.
4. Ghabril M., Bonkovsky H.L., Kum C., Davern T., Hayashi P.H., Kleiner D.E., Serrano J., Rochon J., Fontana R.J., Bonacini M. Liver injury from tumor necrosis factor-alpha antagonists: analysis of thirty-four cases. Clin Gastroenterol Hepatol May 2013, 11(5):558-564. [e3].
5. Kooloos W.M., de Jong D.J., Huizinga T.W., Guchelaar H.J. Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease. Drug Discov Today Feb 2007, 12(3-4):125-131.